Cobas Diagnostic Assay Shows High Accuracy for Chlamydia, Gonorrhea
Researchers find data demonstrate that cobas test can be used reliably in diagnostic testing of symptomatic patients and screening asymptomatic persons.
For treatment of HPV positive low-risk oropharyngeal cancer, cetuximab shows no benefit compared with the standard cisplatin regimen in terms of reduced toxicity and results in worse tumor control.
The risk for herpes zoster (zoster) is elevated during the two years preceding diagnosis and during treatment of hematological cancer.
Zoliflodacin was effective in treating gonococcal urogenital and rectal infections, but less effective in the treatment of pharyngeal gonorrhea.